Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | PKM | P14618 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | HRH1 | P35367 | 1/20 | 1.00 |
| ▸ | HTR2B | P41595 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clemizole SCHEMBL29403196 | 1.00 | HIF1A (1.00) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL13187056 | 0.99 | HIF1A (0.97) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL31707402 | 0.99 | HIF1A (1.00) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL19976072 | 0.99 | HIF1A (0.97) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL19976068 | 0.99 | HIF1A (0.97) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL210095 | 0.99 | HIF1A (1.00) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| SCHEMBL13186938 | 0.99 | HIF1A (0.97) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL19976085 | 0.94 | HIF1A (0.88) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL9444743 | 0.93 | HIF1A (0.86) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 | |
| Clemizole SCHEMBL19976078 | 0.93 | HIF1A (0.86) | HIF1ATDP1CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4004 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746863-A1 | ENDOXIFEN COMPOSITIONS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOF | Atossa Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137654-A1 | COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER | THE REGENTS OF THE UNIV OF CALIFORNIA (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026101937-A1 | COMPOSITIONS COMPRISING (Z)-ENDOXIFEN AND A CDK4/6 INHIBITOR AND METHODS OF USE THEREOF | ATOSSA THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260083706-A1 | 5HT AGONISTS FOR TREATING DISORDERS | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | claimed |
| EP-4043016-B1 | THE 5HT AGONIST CLEMIZOLE FOR USE IN TREATING EPILEPSY DISORDERS | UNIV CALIFORNIA (US) | 2025-10-29 | — | — | EP | claimed |
| US-12447144-B2 | 5HT agonists for treating disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-10-21 | — | — | US | claimed |
| US-12419866-B2 | Compounds and methods for treating an epileptic disorder | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-09-23 | — | — | US | claimed |
| WO-2025151443-A1 | ENDOXIFEN FOR TREATMENT OF RARE CANCERS | ATOSSA THERAPEUTICS, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025133679-A1 | COMPOUNDS AND COMPOSITION FOR DNA PROTECTION | ASSOCIAÇÃO PARA DESENVOLVIMENTO DO CENTRO ACADÉMICO DE INVESTIGAÇÃO E FORMAÇÃO BIOMÉDICA DO ALGARVE, AD-ABC (PT) | 2025-06-26 | — | — | WO | claimed |
| WO-2025137145-A1 | ORAL FORMULATIONS OF (Z)-ENDOXIFEN AND METHODS OF USE THEREOF | ATOSSA THERAPEUTICS, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0673782-B1 | Recording sheets containing pyrrole, pyrrolidine, pyridine, piperidine, homopiperidine, quinoline, isoquinoline, quinuclidine, indole, and indazole compounds | XEROX CORP (US) | 2000-06-14 | — | — | EP | claimed |
| EP-0948359-A1 | COMPOSITIONS CONTAINING LIPOPHILIC OLIGOSACCHARIDE ANTIBIOTIC AND ALBUMIN | SCHERING CORPORATION (US) | 1999-10-13 | — | — | EP | claimed |
| US-5776912-A | Lipophilic oligosaccharide antibiotic compositions | SCHERING CORPORATION (US) | 1998-07-07 | — | — | US | claimed |
| WO-1998028011-A1 | COMPOSITIONS CONTAINING LIPOPHILIC OLIGOSACCHARIDE ANTIBIOTIC AND ALBUMIN | SCHERING CORPORATION (US) | 1998-07-02 | — | — | WO | claimed |
| EP-0538011-B1 | Lipophilic oligosaccharide antibiotic salt compositions | SCHERING CORP (US) | 1997-07-30 | — | — | EP | claimed |
| US-5624914-A | EVERNINOMYCINS, CYCLODEXTRAN DERIVATIVE, NONIONIC SURFACTANT | SCHERING CORPORATION (US) | 1997-04-29 | — | — | US | claimed |
| EP-0610295-A1 | LIPOPHILIC OLIGOSACCHARIDE ANTIBIOTIC SALT COMPOSITIONS | SCHERING CORPORATION (US) | 1994-08-17 | — | — | EP | claimed |
| WO-1993007904-A1 | LIPOPHILIC OLIGOSACCHARIDE ANTIBIOTIC SALT COMPOSITIONS | SCHERING CORPORATION (US) | 1993-04-29 | — | — | WO | claimed |
| EP-0538011-A1 | Lipophilic oligosaccharide antibiotic salt compositions | SCHERING CORPORATION (US) | 1993-04-21 | — | — | EP | claimed |